APAOG Partners with Scynexis to offer Educational Programs in February and March

February 04, 2022 9:51 AM | Becca Liebers (Administrator)

"Itching for a New Treatment for Vaginal Yeast Infections? Ibrexafungerp, A First-in-Class One-Day Oral Antifungal for Vulvovaginal Candidiasis" is the titled of the program being provided by regional directors from Scynexis. APAOG has partnered in order to provide PAs interested in learning more an opportunity during February or March. All sessions are listed here. Please choose one that best fits your location/time zone/ schedule. 

Powered by Wild Apricot Membership Software